Targeted cancer treatment case study: 'I'm so grateful that I can live a normal life'
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Mary Bacon, 66, from Cumbria, was diagnosed with chronic myeloid leukaemia (CML) in 2008. But targeted treatments mean she can now live a normal life.
“Before I was diagnosed, I didn’t know anything about leukaemia, and I put the symptoms I was suffering – bone pain, fatigue – down to old age. So when I found out, I thought the end was near. It was diagnosed in the relatively early stages, so I was lucky. I had an excellent consultant who told me there was a new targeted treatment for the specific genetic mutation I have. Had I been struck with the illness 10 years earlier, I might not have been here now.
I was given Glivec, a drug which deals with the faulty gene which causes the over-production of white blood cells, and I responded well. Now I take nilotinib. There are some side effects, but I’m able to live a normal life. It’s absolutely brilliant news that more people will get targeted treatment. It may not be a cure, but it does mean more people will be able to manage their condition. I’m so grateful to charities like Cancer Research UK who fund such vital work. My daughter Rachel was involved in some of the research work to identify the mutation I have. Normally, scientists don’t get to see the results of their work, but she has seen the positive effect it has had on her own mother.”
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments